Anthim: Completed pivotal trial enrollment

Elusys completed enrollment of 40 adult volunteers in an open-label, U.S. pivotal trial comparing a single dose of 16 mg/kg IV ETI-204 vs. ETI-204 followed by a single dose of IV ciprofloxacin followe...